Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
The obesity-related pathology and Th17 cells.
Atypical inflammatory demyelinating syndromes of the CNS.
Alemtuzumab-induced elimination of HIV-1-infected immune cells.
Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects.
Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
[Melatonin as an inducing factor for multiple sclerosis].
Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Babesia parasitemia rebound after red blood cell exchange.
When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation.
Ophthalmologic aspects of chikungunya infection.
Seasonality of tweets related to multiple sclerosis.
Brain-derived neurotrophic and immunologic factors: beneficial effects of riboflavin on motor disability in murine model of multiple sclerosis.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Current status of biomarker research in neurology.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Patients smoking cannabis are risking their health.
Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis.
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.

Pages